Global Platinum Based Cancer Drug Competitive Landscape Professional Research Report 2024

Research Summary

Platinum-based cancer drugs are a class of chemotherapeutic agents that contain platinum as a central component. The most widely used platinum-based drugs in cancer treatment are cisplatin, carboplatin, and oxaliplatin. These drugs work by forming covalent bonds with DNA molecules, disrupting the DNA structure and interfering with cell division, ultimately leading to cell death. Platinum-based chemotherapy is commonly employed in the treatment of various cancers, including testicular, ovarian, bladder, and lung cancers. While effective, these drugs can cause side effects, and resistance may develop over time. Researchers continue to explore novel platinum-based compounds and combination therapies to enhance efficacy and reduce adverse effects in cancer treatment.

According to DIResearch's in-depth investigation and research, the global Platinum Based Cancer Drug market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Platinum Based Cancer Drug include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories, Mylan, Sun Pharma, Novartis, Debiopharm, Accord Healthcare, SK Chemicals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Platinum Based Cancer Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Platinum Based Cancer Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Platinum Based Cancer Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Platinum Based Cancer Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Platinum Based Cancer Drug Include:

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

Teva

Pfizer

Dr Reddy's Laboratories

Mylan

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Platinum Based Cancer Drug Product Segment Include:

Cisplatin

Oxaliplatin

Carboplatin

Others

Platinum Based Cancer Drug Product Application Include:

Colorectal Cancer

Ovarian Cancer

Lung Cancer

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Platinum Based Cancer Drug Industry PESTEL Analysis

Chapter 3: Global Platinum Based Cancer Drug Industry Porter's Five Forces Analysis

Chapter 4: Global Platinum Based Cancer Drug Major Regional Market Size and Forecast Analysis

Chapter 5: Global Platinum Based Cancer Drug Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Platinum Based Cancer Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Platinum Based Cancer Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Platinum Based Cancer Drug Market Overview

1.1 Product Definition and Statistical Scope

1.2 Platinum Based Cancer Drug Product by Type

1.2.1 Global Platinum Based Cancer Drug Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Cisplatin

1.2.3 Oxaliplatin

1.2.4 Carboplatin

1.2.5 Others

1.3 Platinum Based Cancer Drug Product by Application

1.3.1 Global Platinum Based Cancer Drug Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Colorectal Cancer

1.3.3 Ovarian Cancer

1.3.4 Lung Cancer

1.3.5 Others

1.4 Global Platinum Based Cancer Drug Market Revenue Analysis (2019-2030)

1.5 Platinum Based Cancer Drug Market Development Status and Trends

1.5.1 Platinum Based Cancer Drug Industry Development Status Analysis

1.5.2 Platinum Based Cancer Drug Industry Development Trends Analysis

2 Platinum Based Cancer Drug Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Platinum Based Cancer Drug Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Platinum Based Cancer Drug Market Analysis by Regions

4.1 Platinum Based Cancer Drug Overall Market: 2023 VS 2024 VS 2030

4.2 Global Platinum Based Cancer Drug Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Platinum Based Cancer Drug Revenue and Market Share by Region (2019-2024)

4.2.2 Global Platinum Based Cancer Drug Revenue Forecast by Region (2025-2030)

5 Global Platinum Based Cancer Drug Market Size by Type and Application

5.1 Global Platinum Based Cancer Drug Market Size by Type

5.2 Global Platinum Based Cancer Drug Market Size by Application

6 North America

6.1 North America Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Platinum Based Cancer Drug Market Size by Type

6.4 North America Platinum Based Cancer Drug Market Size by Application

6.5 North America Platinum Based Cancer Drug Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Platinum Based Cancer Drug Market Size by Type

7.4 Europe Platinum Based Cancer Drug Market Size by Application

7.5 Europe Platinum Based Cancer Drug Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Platinum Based Cancer Drug Market Size by Type

8.4 China Platinum Based Cancer Drug Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Platinum Based Cancer Drug Market Size by Type

9.4 APAC (excl. China) Platinum Based Cancer Drug Market Size by Application

9.5 APAC (excl. China) Platinum Based Cancer Drug Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Platinum Based Cancer Drug Market Size by Type

10.4 Latin America Platinum Based Cancer Drug Market Size by Application

10.5 Latin America Platinum Based Cancer Drug Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Platinum Based Cancer Drug Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Platinum Based Cancer Drug Market Size by Type

11.4 Middle East & Africa Platinum Based Cancer Drug Market Size by Application

11.5 Middle East & Africa Platinum Based Cancer Drug Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Platinum Based Cancer Drug Market Revenue by Key Manufacturers (2020-2024)

12.2 Platinum Based Cancer Drug Competitive Landscape Analysis and Market Dynamic

12.2.1 Platinum Based Cancer Drug Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Sanofi

13.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Sanofi Platinum Based Cancer Drug Product Portfolio

13.1.3 Sanofi Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Hengrui Medicine

13.2.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Hengrui Medicine Platinum Based Cancer Drug Product Portfolio

13.2.3 Hengrui Medicine Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 ASK Pharma

13.3.1 ASK Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 ASK Pharma Platinum Based Cancer Drug Product Portfolio

13.3.3 ASK Pharma Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Yi Bai Pharmaceutical

13.4.1 Yi Bai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Yi Bai Pharmaceutical Platinum Based Cancer Drug Product Portfolio

13.4.3 Yi Bai Pharmaceutical Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Qilu Pharmaceutical

13.5.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Qilu Pharmaceutical Platinum Based Cancer Drug Product Portfolio

13.5.3 Qilu Pharmaceutical Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Teva

13.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Teva Platinum Based Cancer Drug Product Portfolio

13.6.3 Teva Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Pfizer

13.7.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Pfizer Platinum Based Cancer Drug Product Portfolio

13.7.3 Pfizer Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Dr Reddy's Laboratories

13.8.1 Dr Reddy's Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Dr Reddy's Laboratories Platinum Based Cancer Drug Product Portfolio

13.8.3 Dr Reddy's Laboratories Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Mylan

13.9.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Mylan Platinum Based Cancer Drug Product Portfolio

13.9.3 Mylan Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Sun Pharma

13.10.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Sun Pharma Platinum Based Cancer Drug Product Portfolio

13.10.3 Sun Pharma Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Novartis

13.11.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Novartis Platinum Based Cancer Drug Product Portfolio

13.11.3 Novartis Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Debiopharm

13.12.1 Debiopharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Debiopharm Platinum Based Cancer Drug Product Portfolio

13.12.3 Debiopharm Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Accord Healthcare

13.13.1 Accord Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Accord Healthcare Platinum Based Cancer Drug Product Portfolio

13.13.3 Accord Healthcare Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 SK Chemicals

13.14.1 SK Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 SK Chemicals Platinum Based Cancer Drug Product Portfolio

13.14.3 SK Chemicals Platinum Based Cancer Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Platinum Based Cancer Drug Industry Chain Analysis

14.2 Platinum Based Cancer Drug Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Platinum Based Cancer Drug Typical Downstream Customers

14.4 Platinum Based Cancer Drug Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support